Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Thomas William Flaig

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Flaig, Thomas

Item TypeName
Academic Article A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.
Academic Article The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell lines.
Academic Article Management of the side effects of androgen deprivation therapy in men with prostate cancer.
Academic Article Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical application.
Academic Article Adjuvant medical therapy for prostate cancer.
Academic Article A renaissance in the medical treatment of advanced prostate cancer.
Academic Article Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Academic Article Low-dose diethylstilbestrol for the treatment of advanced prostate cancer.
Academic Article Optimizing outcomes of advanced prostate cancer: drug sequencing and novel therapeutic approaches.
Academic Article Axitinib, a new therapeutic option in renal cell carcinoma.
Academic Article Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer.
Academic Article Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Academic Article A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Academic Article Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Academic Article Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.
Academic Article Pazopanib synergizes with docetaxel in the treatment of bladder cancer cells.
Academic Article Abiraterone and increased survival in metastatic prostate cancer.
Academic Article Bladder cancer in 2011: the dawn of personalized medicine.
Academic Article Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Academic Article Targeted therapy in advanced urothelial carcinoma.
Concept Neoadjuvant Therapy
Concept Drug Therapy, Combination
Concept Treatment Outcome
Concept Therapies, Investigational
Concept Combined Modality Therapy
Concept Hormone Replacement Therapy
Academic Article Collision renal cell papillary and medullary carcinoma in a 66-year-old man.
Academic Article Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer.
Academic Article Sequencing medical therapy in prostate cancer: not as easy as 1-2-3.
Academic Article Functionalized gold nanorods for thermal ablation treatment of bladder cancer.
Academic Article Metastatic relapse after initial clinical stage I testicular Leydig cell tumor.
Academic Article The prognostic significance of Gleason scores in metastatic prostate cancer.
Academic Article Geriatric considerations in the treatment of advanced prostate cancer.
Academic Article Micropapillary bladder cancer: current treatment patterns and review of the literature.
Academic Article Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Academic Article Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.
Academic Article Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy.
Academic Article Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
Academic Article Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer.
Academic Article Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.
Academic Article Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Academic Article Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials.
Academic Article Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world data.
Academic Article Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
Academic Article Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.
Academic Article Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
Academic Article Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Academic Article Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Academic Article Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.
Academic Article Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction.
Grant Texas EXperimental Cancer Therapeutics Network - TEX CTN
Grant Targeted nanoparticle thermoablation for the treatment of bladder cancer
Academic Article The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model.
Academic Article Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.
Academic Article Initiation of ADT in a Man With Locally Advanced Prostate Cancer and Multiple Cardiovascular Risk Factors.
Academic Article The Changing Treatment Landscape for Metastatic Urothelial Carcinoma.
Academic Article NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
Academic Article Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
Concept Proton Therapy
Concept Molecular Targeted Therapy
Concept Organ Sparing Treatments
Academic Article Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.
Academic Article Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
Academic Article Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study.
Academic Article A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695).
Academic Article TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
Academic Article National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
Academic Article Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer.
Academic Article Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer.
Academic Article Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
Academic Article Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis.
Academic Article Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly.
Academic Article Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
Academic Article Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
Academic Article Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).
Academic Article Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Academic Article A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Academic Article Metabolic and cardiovascular disease risk for Zimbabwean men with prostate cancer receiving long-term androgen deprivation therapy.

Search Criteria
  • Therapeutics

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)